21-31659806-G-C
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_000454.5(SOD1):c.37G>C(p.Gly13Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_000454.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOD1 | ENST00000270142.11 | c.37G>C | p.Gly13Arg | missense_variant | Exon 1 of 5 | 1 | NM_000454.5 | ENSP00000270142.7 | ||
SOD1 | ENST00000389995.4 | c.15+22G>C | intron_variant | Intron 1 of 4 | 3 | ENSP00000374645.4 | ||||
SOD1 | ENST00000470944.1 | n.98G>C | non_coding_transcript_exon_variant | Exon 1 of 5 | 2 | |||||
SOD1 | ENST00000476106.5 | n.114G>C | non_coding_transcript_exon_variant | Exon 1 of 5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 1 Pathogenic:3
The SOD1 gene encodes superoxide dismutase-1, a cytoplasmic antioxidant enzyme that metabolizes superoxide radicals to molecular oxygen and hydrogen peroxide, thus providing a defense against oxygen toxicity.The genomic variant c.37G>C p.Gly13Arg rs121912456 on the SOD1 gene is a missense mutation that results in the substitution of glycine with arginine at the 13th amino acid position of the SOD1 protein. This variant has been associated with amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder characterized by the progressive loss of motor neurons, leading to muscle weakness, atrophy, and respiratory failure.The variant is not found in gnomad 4.1 joint database. The reference nucleotide is conserved across vertebrates. The variant is predicted to be damaging in multiple tools such as CADD 1.7, SIFT, PolyPHen2, M-CAP etc. -
- -
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOD1 protein function. This variant has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 28035186, 11369193, 14506936). ClinVar contains an entry for this variant (Variation ID: 14780). This variant is also known as p.Gly12Arg. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 13 of the SOD1 protein (p.Gly13Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at